June 26, 2015 – Heidrick & Struggles has strengthened its expertise in healthcare and life sciences recruiting with the addition of Greg Lovas as partner to the firm’s Washington, D.C. office. As a member of Heidrick & Struggles’ life sciences practice, Mr. Lovas serves pharmaceutical, medical device, healthcare services, and biotech clients in all phases of growth, from start-ups to multi-billion dollar global leaders. He also works extensively with consumer, for-profit education and private equity clients.
Prior to joining Heidrick & Struggles, Mr. Lovas was a partner at CTPartners, where he was a leader of the firm’s life sciences practice in Asia Pacific. He has a long track record recruiting CEOs, CFOs, COOs, and senior operational and functional executives with an emphasis on general management, marketing, and sales roles. He has also provided clients with guidance concerning board composition, both strategically and by recruiting individuals with the unique skill sets to meet evolving business and governance needs. Before entering executive search, Mr. Lovas was with a Fortune 500 global financial services organization, where he took on a variety of roles in sales management and marketing.
“Greg is a true global consultant and trusted advisor who has helped many great healthcare and life sciences brands establish a presence in Asia,” said John Mitchell, global practice managing partner of the healthcare and life sciences practice. “His expertise will be a huge addition to our team in North America and around the world, as he relocates back to the U.S. following more than five years in Asia. We are fortunate to attract such a stellar search partner and I know our clients, candidates and colleagues will be well looked after.”
Heidrick & Struggles is a provider of integrated senior-level executive search and leadership advisory services. The firm’s healthcare and life sciences practice serves clients in a number of global life sciences companies in diverse sectors, including medical devices and diagnostics, pharmaceuticals and contract research organizations, research and development, healthcare services, biotechnology, and managed care.
Contributed by Dale M. Zupsansky, Managing Editor, Hunt Scanlon Media